Lazy eye or amblyopia has always been a condition that was treatable with glasses and patching of the eyes so long as you were younger than 7 years of age. If you were an adult or older than 8 years of age, you were simply told “Sorry, you are too late. We should have seen you when you were a child.” Well, not any more.
View All information regarding this study
Amblyopia is a brain condition where the brain ignores information from one eye because it is misaligned (due to a turn or squint) or because the 2 eyes have very different refractions or eyesight prescriptions. The traditional treatment is by means of patching i.e. blocking off the good eye with an eye-patch and then “forcing” the brain to accept the bad eye’s vision. If this is done for at least 3 hours per day for enough years and at the right age (less than age 7 years), then the lazy eye may improve.
Up until now there was no treatment available for lazy eye or amblyopia for adults.
UPDATE: Due to unforeseen circumstances, recruitment for this study has been put on hold. As soon as the sponsor is ready to start recruiting, we will contact those on the waiting list. We have no idea when this may be unfortunately and there is a possibility that the study may be cancelled for Europe. These are circumstances beyond our control and please bear this in mind if you do add your name to the waiting list.
Using an eye-patch to block out the good eye, thereby forcing the “lazy eye” to work, has been the hallmark of amblyopia therapy for many many decades.
Amblyotech is a new company spun out from McGill University in Toronto and based on very solid science that is widely published. They have a new treatment for lazy eye or amblyopia that does not involve patching. Their treatment is about integrating the lazy eye back into the binocular (3-D) visual system. The therapy is only one hour per day for 6 – 8 weeks, involves no patching and only requires the wearing of 3-D glasses and playing a game on a specially developed tablet (much like an iPad). As the game develops so the vision in the lazy eye improves and the 3-D visual integration improves. Studies in the USA have shown that more than 90% of patients treated have experienced significant improvements in their visual functioning. Learn more about Amblyotech here.
This is the very first time that a treatment has enjoyed success treating adult patients with lazy eye. The object of the study at the WEC is to determine exactly what type of lazy eye is going to do best with this new revolutionary therapy and will only include adult patients for the moment. Please contact the WEC on 01-2930470 or email [email protected] to register your interest in this study.